These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9389231)

  • 21. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis.
    Op De Beéck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2012 Dec; 12(2):137-43. PubMed ID: 22387973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.
    Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Mahler M; Fritzler MJ; Bossuyt X
    Autoimmun Rev; 2018 Jun; 17(6):533-540. PubMed ID: 29526634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of automated indirect immunofluorescence compared to manual indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Kim J; Lee W; Kim GT; Kim HS; Ock S; Kim IS; Jeong S
    Semin Arthritis Rheum; 2019 Feb; 48(4):728-735. PubMed ID: 29706242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
    Bossuyt X; De Langhe E; Borghi MO; Meroni PL
    Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescent antinuclear antibody and anti-double-stranded DNA antibody testing: a four years experience.
    Anwer F; Abou-Azama AM; Mandourah A; Borja M; Soriano R; Mercado SG
    J Pak Med Assoc; 1997 Sep; 47(9):226-8. PubMed ID: 9361484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunofluorescence tests in immune technics and applications.
    Barnett EV
    Am J Clin Pathol; 1977 Nov; 68(5 Suppl):662-3. PubMed ID: 335877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
    Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
    Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].
    Mierau R
    Z Rheumatol; 2016 May; 75(4):372-80. PubMed ID: 26820723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of multiple antigen substrates to detect antinuclear antibody in canine sera.
    McVey DS; Shuman W
    Vet Immunol Immunopathol; 1991 Mar; 28(1):37-43. PubMed ID: 2053272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Screening Dilution and Automated Reading for Antinuclear Antibody Detection on HEP2 Cells in the Monitoring of Connective Tissue Diseases.
    Depincé-Berger AE; Moreau A; Bossy V; Genin C; Rinaudo M; Paul S
    J Clin Lab Anal; 2016 Sep; 30(5):471-8. PubMed ID: 27225012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative value of commercial kits for ANA testing.
    Russell AS; Johnston C
    Clin Exp Rheumatol; 2003; 21(4):477-80. PubMed ID: 12942700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speckled antinuclear antibodies in keratinocytes--what does it mean?
    Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
    Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antinuclear antibody screening by an enzyme-linked immunosorbent assay using multiple nuclear antigens].
    Iwata H; Aotsuka S; Okawa M; Kinoshita M; Sumiya M
    Ryumachi; 1997 Aug; 37(4):548-55. PubMed ID: 9311280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of anticytoplasmic antibodies found on fluorescent antinuclear antibody testing.
    Tesser JR; Rothberger H; Agudelo C
    J Rheumatol; 1983 Apr; 10(2):227-34. PubMed ID: 6345769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinuclear antibody testing.
    Keren DF
    Clin Lab Med; 2002 Jun; 22(2):447-74. PubMed ID: 12134471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of the immunofluorescence staining patterns and titres of the antinuclear antibody test in paediatric rheumatology setting.
    Baba Ö; Kısaoğlu H; Kalyoncu M
    Turk J Med Sci; 2023 Feb; 53(1):193-198. PubMed ID: 36945955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis.
    Bossuyt X; Cooreman S; De Baere H; Verschueren P; Westhovens R; Blockmans D; Mariën G
    Clin Chim Acta; 2013 Jan; 415():101-6. PubMed ID: 23026234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.